Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Harvard Business School
McKesson
Boehringer Ingelheim
Express Scripts

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Litigation Details for ALTANA PHARMA AG v. TEVA PHARMACEUTICALS USA INC (D.N.J. )

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in ALTANA PHARMA AG v. TEVA PHARMACEUTICALS USA INC
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for ALTANA PHARMA AG v. TEVA PHARMACEUTICALS USA INC (D.N.J. )

Date Filed Document No. Description Snippet Link To Document
2007-02-06 120 formulation patent for the tablet version of the drug, U.S. Patent No. 5,997,903 (the “ ‘903 patent”), while…United States Patent No. 4,758,579 (the “ ‘579 patent”). The ‘579 patent is one of two patents which make…second patent which comprises Protonix IV is United States Patent No. 6,780,881 (the “ ‘881 patent”). The…on the ‘881 patent, only the ‘579 patent; (2) Plaintiffs could have sued on the ‘881 patent concurrently…the drug does not infringe existing patents or that any such patents are invalid. Defendants answered Plaintiffs External link to document
2012-12-20 1231 is a patent infringement action to enforce United States Patent No. 4,758,579 (“the ‘579 patent”). The…tablets infringes claims 22 and 25 of U.S. Patent No. 4,758,579, if those claims are valid and enforceable…tablets infringes claims 22 and 25 of U.S. Patent No. 4,758,579, if those claims are valid and enforceable…25 of the ‘579 patent are invalid for obviousness and obviousness-type double patenting. Simultaneously… any patented invention, within the United States or imports into the United States any patented invention External link to document
2013-01-11 1236 This is a patent infringement action to enforce United States Patent No. 4,758,579 ("the '…claims 22 and 25 of U.S. Patent No. 4,758,579, if those claims are valid and …tablets infringes claims 22 and 25 of U.S. Patent No. 4,758,579, if those claims are valid and enforceable…'579 patent"). The asserted claims of the '579 patent- claims 22 and 25 - cover a chemical… the '579 patent are invalid for obviousness and obviousness-type double patenting. Simultaneously External link to document
2013-02-11 1244 is a patent infringement action to enforce United States Patent No. 4,758,579 (“the ‘579 patent”). The…25 of the ‘579 patent are invalid for obviousness and obviousness-type double patenting Simultaneously… the Panduit test, the patent owner must prove: (1) a demand for the patented product, (2) an absence… exclusive licensee of the patented product, made all sales of the patented product, and collected all…The asserted claims of the ‘579 patent - claims 22 and 25 - cover a chemical compound named Pantoprazole External link to document
2013-03-26 1292 is a patent infringement action to enforce United States Patent No. 4,758,579 (“the ‘579 patent”). The…infringement of the patent holder’s patent. See Poly-America, 383 F.3d at 1311 (holding that patent holder could…25 of the ‘579 patent are invalid for obviousness and obviousness-type double patenting Simultaneously…possibility that a patent holder may be able to recover a related entity’s damages if the patent holder and the…entitling a subsidiary patent holder to recover damages for injuries to its non-patent holding parent.4 For External link to document
2013-03-26 1294 is a patent infringement action to enforce United States Patent No. 4,758,579 (“the ‘579 patent”). The… (“ What patent misuse is about, in short, is patent leverage,” i.e., the use of the patent power to …constitutes patent leveraging The Federal Circuit has defined patent leverage as “the use of the patent power…(“What patent misuse is about, in short, is ‘patent leverage,’ i.e., the use of the patent power to… finds that patent leverage is a required element of per se patent misuse, and that patent leverage is External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Express Scripts
Colorcon
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.